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Human and simian immunodeficiency viruses (HIV and SIV, respectively) use chemokine receptors as coreceptors along
with CD4 to mediate viral entry. Several orphan receptors, including GPR1, GPR15, and STRL33, can also serve as
coreceptors for a more limited number of HIV and SIV isolates. We investigated whether these orphan receptors could
function as efficient coreceptors for a diverse group of HIV and SIV envelopes (Envs) in comparison with the principal
coreceptors CCR5 and CXCR4. We found that a limited number of HIV-1 isolates could mediate inefficient cell–cell fusion with
the orphan receptors relative to CCR5 and CXCR4; however, none of the orphan receptors tested could support pseudotype
virus infection despite robust infection via CCR5 or CXCR4. All except one of the SIV Envs tested mediated some degree of
cell–cell fusion and pseudotype infection, with target cells expressing at least one of these orphan receptors, although CCR5
proved to be the most efficient coreceptor for infection. Only one SIV Env protein, BK28, could mediate infection using GPR1
as a coreceptor, albeit much less efficiently than with CCR5. In addition, use of these coreceptors did not correlate with the
published tropism of the SIV clones and was strictly CD4 dependent for both SIV and HIV. We also examined the expression
of these molecules in cell lines and primary cells widely used for virus propagation and as targets for infection. All cells
examined expressed STRL33, a more limited number expressed GPR15, and GPR1 was much more restricted in its
expression pattern. Taken together, our results indicate that GPR15 and STRL33 are rarely used by HIV-1 but are more
frequently used by SIV strains, although not in a manner that correlates with SIV tropism. © 1998 Academic Press
INTRODUCTION
Infection with the human or simian immunodeficiency
virus (HIV or SIV, respectively) induces an acquired im-
mune deficiency syndrome in humans or Asian ma-
caques, respectively. This disease is characterized by
loss of CD41 T cells, a chronic wasting syndrome,
lymphadenopathy, diarrhea, and opportunistic infections.
A variety of CD41 cell types are targets for infection,
including T cells, monocytes, macrophages, and micro-
glia. Virus isolates are frequently characterized by their
ability to replicate in these cell types, particularly by
whether they can productively infect macrophages. Gen-
erally, the most important determinants of viral tropism
map to the envelope (Env) protein (Chesebro et al., 1991;
Fouchier et al., 1992; Hwang et al., 1991; O’Brien et al.,
1990; Shioda et al., 1991; Westervelt et al., 1991; West-
ervelt et al., 1992) and govern the ability of the virus to
enter various CD41 cell types. The identification of a
number of chemokine and orphan seven transmembrane
domain receptors as coreceptors that are required in
addition to CD4 for HIV and SIV to infect cells has
enhanced our understanding of the role of the Env pro-
tein in determining viral tropism (reviewed in (Berger,
1997; Bieniasz and Cullen, 1998; Broder and Collman,
1997; Doms and Peiper, 1997; Moore et al., 1997).
Both HIV and SIV use chemokine receptors as core-
ceptors to mediate membrane fusion and viral entry in
the presence of CD4 (Alkhatib et al., 1996; Berson et al.,
1996; Chen et al., 1997; Choe et al., 1996; Deng et al.,
1996; Doranz et al., 1996; Dragic et al., 1996; Edinger et
al., 1997a; Feng et al., 1996; Marcon et al., 1997). CCR5 is
expressed in macrophages but not in most T cell lines
(Alkhatib et al., 1996; Chen et al., 1997; Deng et al., 1997;
Kirchhoff et al., 1997; Wu et al., 1997; Yi et al., 1998) and
is used as a coreceptor by R5 (macrophage-tropic) virus
strains. Viruses that replicate in T cell lines use CXCR4
as a coreceptor (X4 or T-tropic viruses), and this chemo-
kine receptor is expressed at high levels on most trans-
formed T cell lines (Bleul et al., 1997; Endres et al., 1996;
Loetscher et al., 1994). Dual-tropic viruses (R5X4) use
both coreceptors and can replicate in both macrophages
and T cell lines (Choe et al., 1996; Doranz et al., 1996). All
HIV-1 strains characterized to date use CCR5, CXCR4, or
both molecules as coreceptors, suggesting that these
are the principal HIV-1 coreceptors (Doms and Moore,
1998). The high level of resistance to HIV-1 infection in
individuals who lack CCR5 indicates that CCR5 is criti-
cally important in vivo (Dean et al., 1996; Huang et al.,
1996; Liu et al., 1996; Michael et al., 1997; Samson et al.,
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1996). Cells derived from CCR5-negative individuals can-
not be infected by viruses that use only CCR5 as a
coreceptor but can be infected by viruses that use
CXCR4 (Liu et al., 1996; Rana et al., 1997; Samson et al.,
1996; Yi et al., 1998). Some virus isolates can use addi-
tional coreceptors to infect CD41 cells; 10 seven-trans-
membrane-spanning molecules have been described so
far that can serve as alternative HIV-1 coreceptors in
vitro in addition to CCR5 and CXCR4 (Choe et al., 1998;
Deng et al., 1997; Doranz et al., 1996; Edinger et al., 1998;
Farzan et al., 1997a; Liao et al., 1997; Reeves et al., 1997;
Rucker et al., 1997b; Samson et al., 1998). The ability to
use these alternative coreceptors may help explain the
finer points of HIV tropism; for instance, certain HIV-1
isolates have been reported to enter microglia by using
CCR3 as a coreceptor (He et al., 1997).
SIV tropism is less clearly defined by chemokine re-
ceptor use patterns. Despite the fact that SIV tropism has
been shown to map largely to Env (Banapour et al.,
1991b; Hirsch et al., 1994; Kirchhoff et al., 1994; Mori et
al., 1992), both M- and T-tropic SIV strains use CCR5, but
not CXCR4, as a coreceptor, defying the R5 and X4
designations given to HIV-1 strains (Chen et al., 1997;
Edinger et al., 1997a; Marcon et al., 1997). Other mole-
cules besides CCR5 can clearly serve as SIV corecep-
tors because a number of CCR5-negative T cell lines,
such as Molt 4 clone 8, CEMx174, and U87-CD4 cells, as
well as human peripheral blood mononuclear cells from
CCR5-negative individuals, can be infected by several
SIV strains (Chen et al., 1997; Hill et al., 1997). In 1997,
three orphan seven-transmembrane receptors that could
serve as SIV coreceptors were identified: GPR1, GPR15
(BOB), and STRL33 (Bonzo) (Deng et al., 1997; Farzan et
al., 1997a). Using cell–cell fusion and reporter virus in-
fection assays, we investigated whether the use of these
coreceptors could help account for SIV tropism or the
finer levels of HIV tropism. Because no ligands or anti-
bodies exist to these molecules, blocking studies to
definitively address whether viruses use these mole-
cules to enter primary cell types could not be performed.
Instead, we evaluated the potential impact of these co-
receptors on viral tropism by determining how many
isolates of defined tropism could use these molecules
for fusion and infection, how efficiently these molecules
functioned as coreceptors for Envs of different tropisms,
and how widely expressed the receptors were among
cells permissive for various viral strains. Because many
primary SIV strains are able to use CCR5 to infect cells in
the absence of CD4 (Edinger et al., 1997b), we also
determined whether isolates capable of using these mol-
ecules for infection could do so in a CD4-independent
fashion. We found that (1) these orphan receptors func-
tioned inefficiently as coreceptors for most HIV-1 strains,
(2) GPR15 and STRL33 were used efficiently by a number
of SIV strains, (3) use of these orphan receptors did not
obviously correlate with SIV or HIV tropism, and (4) use of
GPR1, GPR15, and STRL33 was strictly CD4-dependent.
RESULTS
Determination of coreceptor use patterns using a
cell–cell fusion assay
To evaluate the ability of a wide range of HIV and SIV
Env proteins to mediate membrane fusion through inter-
actions with CD4 and the orphan receptors GPR1,
GPR15, and STRL33, we used a gene reporter cell–cell
fusion assay (Nussbaum et al., 1994; Rucker et al.,
1997a). Briefly, env genes were expressed in effector
cells either by transfection or by infection with recombi-
nant vaccinia viruses. Effector cells were also infected
with a recombinant vaccinia virus expressing T7 poly-
merase. Coreceptor genes under constitutive promoters,
CD4 under the control of the cytomegalovirus (CMV)
promoter, and luciferase under the control of the T7
promoter were expressed in the target cells by transient
transfection. Under these conditions, high levels of both
Env and coreceptor are expected to be expressed, and if
cell–cell fusion occurs, luciferase will be produced.
The majority of the HIV-1 Envs tested in this assay
were unable to use GPR1 as a coreceptor for cell–cell
fusion, although Env proteins derived from six primary
isolates inefficiently mediated fusion with GPR1-positive
cells (Table 1). Only the R5 strain ADA was able to
mediate efficient membrane fusion with cells expressing
CD4 and GPR1. The HIV-2/ST Env (R5) was also able to
mediate fusion with cells expressing GPR1 and CD4. A
large panel of SIV Envs were also evaluated for the
ability to use GPR1 (Table 2). In marked contrast to the
results obtained with HIV-1 Env proteins, all of the SIV
Envs tested were able to fuse with cells expressing this
coreceptor with varying degrees of efficiency. Envs de-
rived from SIVmac251 (BK28), SIVmac239, SIVmac316,
SIVmac316mut, SIV/17E, and SIV/17E-Fr were able to
mediate fusion through GPR1 nearly as efficiently as
through CCR5. However, use of GPR1 as a coreceptor by
either HIV-1 or SIV strains did not correlate with viral
tropism.
GPR15 was next evaluated as an HIV-1 coreceptor.
Interestingly, all virus strains that used GPR1 as a core-
ceptor could also mediate fusion with cells expressing
CD4 and GPR15 (Table 1). Only a single virus isolate,
YU2, was able to mediate fusion with cells expressing
GPR15 but not with cells expressing GPR1. GPR15
shares significant sequence homology with GPR1
(Heiber et al., 1996), which may help explain this finding.
In all cases, GPR15 supported HIV-1 Env-mediated cell–
cell fusion inefficiently relative to the principal coreceptor
(CCR5 or CXCR4). The HIV-2/ST Env protein also sup-
ported fusion through GPR15 (Table 1). All 16 of the SIV
Envs tested were able to fuse with cells expressing
GPR15 (Table 2). GPR15 supported fusion by the SIV-
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mac251, SIVmac239, SIVmac316, and SIVsm543/B10 Env
proteins nearly as efficiently as with cells expressing
CCR5; in fact, higher signals were obtained when GPR15
was available as a coreceptor than with CCR5 for the
only African green monkey (agm) isolate tested, Sab1.4.
Many other SIV Env proteins mediated fusion with
GPR15-positive cells at intermediate levels. As for GPR1,
however, use of GPR15 by either HIV-1 or SIV Env pro-
teins did not correlate with viral tropism.
A larger number of HIV-1 Env proteins were able to
mediate fusion through STRL33 than through GPR1 or
GPR15. In most cases, fusion with STRL33 was relatively
inefficient, although two Env proteins cloned from primary
isolates mediated fusion with STRL33-positive cells at lev-
els approximately half of that observed with CCR5 (Table 1).
Previous studies are in good agreement with our fusion
results with the exception that BaL did not use STRL33 for
fusion in our assay and HIV-1 89.6 did not use STRL33
nearly as efficiently as previously reported (50% vs 14%)
(Liao et al., 1997). These differences may reflect the fact that
STRL33 was expressed using a vaccinia-driven T7 pro-
moter in the study by Liao et al. (1997), whereas we ex-
pressed STRL33 using the CMV promoter in our cell–cell
fusion assay. The higher levels of expression that can be
achieved with the vaccinia virus-T7 system may account for
these discrepancies. Indeed, expression levels have been
shown to strongly influence coreceptor activity for CCR3
and CCR5 (Kozak et al., 1997; Platt et al., 1998; Rucker et al.,
1997b). The HIV-2/ST Env also fused with cells expressing
STRL33 in combination with CD4 (Table 1). As for GPR1 and
GPR15, all of the SIV Envs tested fused with cells express-
ing STRL33. SIVmac251, SIVmac239, SIVmac316,
SIVmac316mut, SIV/17E, SIV/17E-Fr, SIVsmDB670 Cl3, and
SIVsmPBj6.6 fused equally well with cells expressing CD4
and STRL33 as with targets expressing CD4 and CCR5
(Table 2).
In summary, a variety of HIV-1, an HIV-2, and multiple
SIV Envs were able to use GPR1, GPR15, and STRL33 as
viral coreceptors in a cell–cell fusion assay. However,
none of these orphan receptors supported highly effi-
cient fusion for the HIV-1 Env proteins examined, nor did
their use correlate with CCR5 or CXCR4 use. The ineffi-
cient use of these receptors by the HIV-1 strains exam-
ined here suggests that these molecules do not serve as
efficient coreceptors for HIV-1 in vivo. By contrast, all 16
of the SIV Env proteins tested used GPR1, GPR15, and
STRL33 as coreceptors to at least some degree, often
very efficiently. Thus, these receptors are more likely to
serve as relevant coreceptors for SIV, although their use
does not correlate with SIV tropism.
Evaluation of GPR1, GPR15, and STRL33 as
coreceptors using luciferase reporter viruses
Many of the Envs tested in the cell–cell fusion assay
were also tested in a pseudotyped reporter virus sys-
TABLE 1
HIV Env-Mediated Cell–Cell Fusion
Env Clade Class CCR5 CXCR4 GPR1 GPR15 STRL33
89.6 B R5X4 111 111 2 2 1
DH12 B R5X4 111 111 1 1 1
RF B R5X4 111 111 2 2 2
93Z4001.3 D R5X4 1 111 1 1 11
BK132 B R5X4 1 111 2 2 1
ADA B R5 111 1 11 111 1
JR-FL B R5 111 2 2 2 2
YU2 B R5 111 2 2 1 2
BaL B R5 111 2 2 2 2
SF162 B R5 111 2 2 2 1
91US005.11 B R5 111 2 1 1 2
92BR019.10 F/B R5 111 2 1 1 11
92UG031.7 A R5 111 2 2 2 1
93BR029.2 F R5 111 2 2 2 2
UG37-8 A R5 111 2 2 2 1
RW20-5 A R5 111 2 2 2 1
TH22-4 E R5 111 2 1 1 1
IIIB B X4 2 111 2 2 1
92UG024.2 D X4 2 111 1 1 1
HIV-2/ST R5 111 2 11 11 11
Note. Cell–cell fusion assays were performed using target cells expressing the indicated coreceptors, CD4, and luciferase under the control of the
T7 promoter and effector cells expressing the indicated envelope protein and T7 polymerase. Luciferase activity is expressed as the percentage of
the value obtained for the principal coreceptor (indicated by shading) for each envelope. Signal-to-noise ratio with CCR5 or CXCR4 ranged from 25
to 500 depending on the Env.
111, .70%; 11, 40–69%, 1, 10–39%, and 2 ,10% of the signal with the principal receptor.
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tem. Some Envs, such as HIV-1 89.6, failed to
pseudotype and could not be tested. Pseudotyped
viruses bearing the HIV-1 ADA, BaL, YU2, JR-FL, and
NL4–3 Env proteins were unable to enter target cells
cotransfected with CD4 and either GPR1, GPR15, or
STRL33 despite the fact that several of these Envs
could use these coreceptors for cell–cell fusion, albeit
inefficiently (Fig. 1a, Table 1). We suspect that these
discrepancies result from differences in Env density
on effector cells in the cell–cell fusion assay and
on pseudotyped virions because the target cells in
both cases were transiently transfected with identical
receptor and coreceptor constructs. Our results are
consistent with two previous studies that showed
that ADA and YU2 were able to infect cells express-
ing GPR15 (Deng et al., 1997; Farzan et al., 1997a).
Infection of GPR15- or STRL33-positive cells with
these viruses was observed to be ,1% the level ob-
tained with CCR5 using a CAT reporter system (Farzan
et al., 1997a) and 1–10% of the CCR5 signal for these
viruses in the luciferase reporter system (Deng et al.,
1997). Thus, consistent with the cell–cell fusion assay,
our results suggest that GPR1, GPR15, and STRL33 do
not serve as efficient coreceptors for most HIV-1
strains.
The SIV Env proteins were also used to make pseudo-
typed reporter viruses. Although several of the SIVs
did use GPR15 and STRL33 as coreceptors for infec-
tion, CCR5 invariably served as the most efficient
coreceptor for viral infection for all Envs tested (Fig.
1a). Only the Env of BK28 was able to mediate infec-
tion through GPR1, although the efficiency of infection
relative to that obtained with CCR5 was greatly re-
duced from results obtained with the cell–cell fusion
assay. In general, these orphan receptors supported
virus infection less efficiently than they supported cell-
–cell fusion relative to levels obtained with CCR5. Envs
that could efficiently use GPR15 for infection included
SIVmacBK28, SIV/17E-Fr, SIVsmDB670 clones 3 and
12, and SIVsm543 (Fig. 1a). STRL33 was a efficient
coreceptor for infection for SIVmacBK28, SIVmac1A11,
SIV/17E-Fr, SIVsmDB670 Cl3, and SIVmacCP-MAC
(Fig. 1a). However, the ability to use these orphan
receptors as coreceptors for infection did not correlate
with reported Env tropism (Fig. 1a and Table 2).
We recently found that many SIV strains can infect
CD4-negative, CCR5-positive cells (Edinger et al., 1997b).
The ability of some virus strains to infect cells in a
CD4-independent manner may broaden viral tropism. In
fact, infection of primary rhesus macaque brain capillary
endothelial cells, which lack CD4, by neurotropic SIV
strains is mediated by CCR5 (Edinger et al., 1997b).
Therefore, we determined whether any of the Env clones
were able to support infection of cells expressing GPR15
or STRL33 in the absence of CD4. We found that utiliza-
tion of both GPR15 and STRL33 was strictly CD4 depen-
dent, even by viral Env proteins that can use CCR5
independently of CD4 (data not shown).
Infection of GHOST cells stably expressing GPR15
and STRL33
In an attempt to address the importance of expres-
sion levels for the ability of an Env to mediate infection
through a given coreceptor, we also performed infec-
tion experiments on GHOST cells stably expressing
CCR5, GPR15, or STRL33. Because antibodies to CCR5
are readily available, we determined the expression
level of CCR5 on transiently transfected 293T cells and
on GHOST-CCR5 cells. Cells were stained with an
isotype-matched irrelevant antibody (mouse IgG), two
antibodies to CCR5 (45531 and CTC8), and an antibody
to CD4 (Q4120), as described in Materials and Meth-
ods. Using two different antibodies to CCR5, we found
that the mean channel fluorescence (MCF) of trans-
fected 293T cells was ;10-fold higher than that ob-
tained with GHOST-CCR5 cells, whereas the MCF on
GHOST-CCR5 cells with an antibody against CD4 was
nearly equivalent (75%) to the value obtained with
transfected 293T cells (data not shown). Because no
ligands or antibodies are known for GPR15 or STRL33,
similar experiments could not be performed for these
coreceptors. However, it is likely that GHOST cells
TABLE 2
SIV Env-Mediated Cell–Cell Fusion
Env Tropism CCR5 GPR1 GPR15 STRL33
SIVmac251(v194) 111 1 1 111
SIVmac251(BK28) 111 111 111 111
SIVmac239 T 111 111 111 111
SIVmac316 M 111 111 111 111
SIVmac316m T 111 111 111 111
SIVmac17E M 111 111 11 111
SIVmac17E/Fr M 1 brain 111 111 11 111
SIVmac1A11 M 111 1 1 11
SIVsmDB670 CI3 111 11 11 111
SIVsmDB670 CI12 111 1 11 1
SIVsm62A T 111 11 11 11
SIVsm62D M 111 11 1 1
SIVsm543 M 111 11 1 11
SIVsm543/B10 brain 111 11 111 11
SIVsmPBj6.6 111 11 11 111
SIVagmSab1.4 111 11 111 11
Note. Cell–cell fusion assays were performed as described in Table
1 and in the text. Tropism designations are taken from the literature
(Anderson et al., 1993; Banapour et al., 1991a; Hirsch et al., 1994, 1997;
Kirchhoff et al., 1994). Luciferase activity is expressed as the percent-
age of the value obtained for CCR5. The coreceptor producing the
greatest degree of cell–cell fusion is indicated by shading. Signal-to-
noise ratio with CCR5 or CXCR4 ranged from 25 to 500 depending on
the Env.
111, .70%; 11, 40–69%; 1, 10–39%; and 2, ,10% of the CCR5
signal.
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express lower levels of GPR15 and STRL33 than trans-
fected 293T cells based on our results with the
GHOST-CCR5 line.
When SIVmac1A11, SIVsmDB670 Cl3, and SIVmacCP-
MAC pseudotyped viruses were used to infect GHOST
cells, we found that their ability to infect either GPR15
or STRL33 GHOST cells was generally reduced rela-
tive to the results we obtained when these receptors
were transiently expressed (Figs. 1a and 1b). For ex-
ample, Envs derived from SIVmac1A11 and SIVmacCP-
MAC used STRL33 at 10% and 17% of the level of
CCR5, respectively, rather than the 42% and 66% val-
ues observed for transfected cells. The SIVsmDB670
Cl3 Env, however, used STRL33 at 21% of the efficiency
it used CCR5 on GHOST cells, which is in complete
agreement with results obtained on transiently trans-
fected cells. GPR15 use by SIVsmDB670 Cl3 Env in
GHOST cells was, in contrast, markedly reduced from
48% of the CCR5 signal to 13%. These results suggest
that either expression levels of coreceptors or the
cellular context in which they are expressed can affect
their use as SIV coreceptors. Moreover, these results
demonstrate that GPR15 and STRL33 can function as
SIV coreceptors in multiple cell types.
Evaluation of GPR1, GPR15, and STRL33 expression
patterns using reverse transcription-polymerase
chain reaction
Although the expression pattern for GPR1, GPR15, and
STRL33 has been described in a limited number of cell
types (Deng et al., 1997; Farzan et al., 1997a; Liao et al.,
1997), many cell lines commonly used to propagate virus
or as targets for experimental infection have not been
evaluated for expression of these receptors. Because no
ligands or antibodies to these molecules exist, their
FIG. 1. Luciferase reporter virus infection assays. (a) 293T or CCCS target cells were transiently transfected with CD4 and the indicated coreceptor.
(b) Stably transduced GHOST cells and the coreceptor negative parent cell line were infected with luciferase virus pseudotypes bearing the indicated
SIV or HIV-1 Env proteins. Luciferase activity in cell lysates was determined 3–4 days after infection and expressed as the percentage of the signal
obtained with the principal coreceptor for each virus. Signal-to-noise values in these assays were 25–500 depending on the Env pseudotyped.
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expression patterns can only be evaluated by Northern
analysis or reverse transcription-polymerase chain reac-
tion (RT-PCR). We used a one-tube RT-PCR system to
detect orphan receptor transcripts. If no product was
detected during the first round of amplification, a more
sensitive nesting procedure was performed on both ex-
perimental and negative control samples. GPR1 mRNA
expression was relatively restricted as transcripts were
found only in U87, 293T, HeLa, and CEMss cells and on
one occasion in phytohemagglutinin (PHA) and interleu-
kin (IL)-2-stimulated PBLs (Fig. 2 and Table 3). GPR15
was more widely expressed, with transcripts being iden-
tified in the first round of amplification in CEMX174,
Hut-78, C8166, monocytes, monocyte-derived macro-
phages, and PBLs stimulated by three different proto-
cols. GPR15 transcripts were also detected in PM1 and
U937 cells when nested PCR was performed on the
RT-PCR product (Table 3). STRL33 transcripts were de-
FIG. 2. Expression pattern of GPR1, GPR15, and STRL33 in primary cells and cell lines. RT-PCR was performed on RNA extracted from the indicated
cells, and the reaction products were separated on 2% agarose gels. Bright bands in size marker lanes correspond to 1500- or 600-bp fragments as
indicated, and less intense bands form a ladder of fragments differing by 100 bp in length. Plasmid DNA was amplified as a positive control, and water
was used as template in a negative control. When necessary, nested PCR was performed on the product of the RT-PCR. b-Actin lanes correspond
to (1) U87, (2) 293T, (3) monocytes, (4) MDM, (5) PBMCs, (6) Hut-78, (7) PM1, and (8) HOS.
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tected in all cell types examined (Fig. 2 and Table 3).
Occasionally, STRL33 could be detected after RT-PCR,
but in most cases nested PCR was required before
STRL33 transcripts were detected. The results obtained
here may help explain elevated background levels of
cell–cell fusion or virus infection seen in some systems
or the ability of certain cell lines to support the replica-
tion of particular viral strains. For example, the molecular
clone SIV/17E-Fr is able to replicate in 293T cells stably
transfected with CD4 (personal communication, Janice
Clements and James Hildreth); this fact may be ex-
plained by the detection of STRL33 transcripts in this cell
line as SIV/17E-Fr uses STRL33 but not GPR1 as a
coreceptor for infection (Fig. 1a).
DISCUSSION
The ability of a viral isolate to use different chemokine
receptors to infect cells has a significant impact on viral
tropism. In addition to CCR5 and CXCR4, at least 10 other
seven-transmembrane molecules can serve as corecep-
tors for one or more HIV-1 strains in vitro (Choe et al.,
1998; Deng et al., 1997; Doranz et al., 1996; Edinger et al.,
1998; Farzan et al., 1997a; Liao et al., 1997; Reeves et al.,
1997; Rucker et al., 1997b; Samson et al., 1998). Use of
these alternative coreceptors may expand HIV tropism
by enabling a virus to infect a wider variety of cell types.
In the case of SIV, tropism is less simply explained by
coreceptor use because the ;20 isolates examined to
date all use CCR5 as a coreceptor regardless of cell or
apparent tissue tropism, whereas none have been re-
ported to use CXCR4 (Chen et al., 1997; Edinger et al.,
1997a; Hill et al., 1997; Kirchhoff et al., 1997; Marcon et
al., 1997). Therefore, the ability to use one of the alter-
native coreceptors might influence SIV tropism.
Any attempt to resolve the contributions orphan recep-
tors make to HIV or SIV transmission or pathogenesis is
currently limited by reagents because the ligands for
these receptors remain elusive and antibodies have not
yet been developed. Use of blocking agents such as
ligands or antibodies are currently the best means of
addressing the relevance of a given seven-transmem-
brane molecule for virus infection of primary cells in vitro.
In the absence of blocking agents, several criteria for
addressing the potential relevance of receptors can be
defined: (1) how many viruses are able to use a given
molecule as a coreceptor for infection, (2) how efficiently
these viruses use the molecule as a coreceptor relative
to CCR5 or CXCR4, (3) whether the ability to use a
particular molecule as a coreceptor correlates com-
pletely or in large part with cell or tissue tropism, (4)
whether the potential coreceptor is expressed on rele-
vant target cells in vivo at levels that can support virus
infection, and (5) whether use of the coreceptor is de-
pendent on the expression of CD4. We attempted to
address these questions for the orphan receptors GPR1,
GPR15, and STRL33 by using a large panel of divergent
HIV and SIV isolates to further clarify their contribution to
viral pathogenesis.
Although several HIV-1 Envs were able to mediate
relatively inefficient cell–cell fusion using GPR1, GPR15,
or STRL33 as coreceptors (Table 1), none of the Envs
tested mediate infection in the context of a pseudotyped
virion using these molecules as coreceptors (Fig. 1a).
The result that few HIV-1 strains use these orphan re-
ceptors as coreceptors is not unexpected because cells
isolated from D32 CCR5 homozygous individuals (which
lack CCR5 but likely express GPR15 and STRL33) are
resistant to infection with a variety of R5 virus strains (Liu
et al., 1996; Rana et al., 1997; Samson et al., 1996; Yi et al.,
1998). Thus far, infection of CCR5-negative cells derived
from D32 CCR5 homozygotes by HIV-1 has been shown
to be CXCR4 dependent (Yi et al., 1998). Therefore, utili-
zation of GPR1, GPR15, or STRL33 by HIV-1 in primary T
cells or macrophages is likely to be a relatively rare
event.
In contrast with HIV-1 Env proteins, all SIV Envs tested
were able to mediate cell–cell fusion using GPR1, GPR15,
and STRL33 as coreceptors (Table 2). When these Envs
TABLE 3
Expression Pattern of GPR1, GPR15, and STRL33
in Primary Cells and Cell Lines
CCR5 CXCR4 GPR1 GPR15 STRL33
Jurkat 2 1 2 2 1nest
CEMss 1 1nest 2 1
SupT1 2 1 2 N.D. 1
Hut-78 2 1 2 1 1
C8166 2 1 1nest
CEMX174 2 1 2 1 1nest
Molt4 clone 8 2 1 2 2 1nest
PM1 1 2 1nest 1nest
U937 2 1 2 1nest 1nest
THP-1 2 2 2 1nest
IL-2 PBMC 1 1 2 1 1
Monocytes 1 1 2 1 1
Macrophages 1 1 2 1 1
U87 2 2 1nest 2 1nest
HeLa 2 1 1nest 2 1nest
293T 2 1 1nest 2 1
HOS 2 1 2 2 1nest
Note. RT-PCR was performed on RNA extracted from the indicated
cells as described in the text. T cell and monocyte-like cell lines are
grouped in the first section, primary cells in the second, and nonim-
mune system-derived cells lines are listed in the third. CCR5 and
CXCR4 expression data are taken from the literature where available
(Alkhatib et al., 1996; Bleul et al., 1997; Chen et al., 1997; Deng et al.,
1996, 1997; Endres et al., 1996; Kirchhoff et al., 1997; Kuhmann et al.,
1997; Lavi et al., 1997; Loetscher et al., 1994; Wu et al., 1997; Yi et al.,
1998).
2, No mRNA detected; 1, specific band detected after RT-PCR;
1nest , specific band detected when nested PCR followed RT-PCR; N.D.,
not determined.
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were tested in the luciferase virus infection assay sys-
tem, the coreceptor use pattern was more restricted (Fig.
1a). Despite efficient use of GPR1 as a coreceptor for
fusion by Envs such as SIVmacBK28 and SIV/17E-Fr, this
molecule functioned very weakly or not at all as a core-
ceptor for infection. Because the target cells in both
systems were transiently transfected cells, this discrep-
ancy may be due to differences in Env expression levels
on effector cells in the fusion assay and pseudotyped
virions in the infection assay. Alternatively, the topologic
differences between fusion of two cells and of a cell and
a virion may contribute to this disparity. It is less likely
that postentry, receptor-related events could account for
these differences because multiple studies have shown
that signaling is not required for productive infection by
HIV or integration of luciferase reporter viruses pseudo-
typed with HIV or SIV Envs (Alkhatib et al., 1997; Doranz
et al., 1997; Edinger et al., 1997a; Farzan et al., 1997b;
Gosling et al., 1997).
In contrast to GPR1, both GPR15 and STRL33 sup-
ported relatively efficient infection by pseudotyped viri-
ons bearing the Env proteins from several M- and T-
tropic SIV strains, although CCR5 always resulted in the
highest levels of luciferase activity (Figs. 1a and 1b). The
ability to use GPR15 or STRL33 for infection did not
correlate with the reported tropism of the SIV Envs,
making it unlikely that these molecules play an important
role in governing macrophage tropism for SIV. The ques-
tion of how Env determines SIV tropism when all isolates
use CCR5 but only a subset replicate efficiently in mac-
rophages remains open. Previous studies have sug-
gested that M- and T-tropic SIVs may interact with CCR5
differently (Edinger et al., 1997a), and more recent work
has suggested that Env signaling through coreceptors
may correlate with tropism (Davis et al., 1997; Weissman
et al., 1997). Regardless of whether GPR15 and STRL33
play a role in determining SIV M-tropism, these receptors
are widely used by divergent, primary virus strains,
making it more likely that these alternative coreceptors
play at least some role in SIV infection. SIVs can grow in
D32 CCR5 human peripheral blood mononuclear cells
(PBMCs) (Chen et al., 1997), and virtually all SIVs grow in
CEMx174 or Molt4 clone 8 cells, which do not express
CCR5 (Chen et al., 1997; Kirchhoff et al., 1997; Wu et al.,
1997). Because most, if not all, SIV strains do not use
CXCR4 as a coreceptor, entry into these cell types most
likely results from the use of orphan receptors as core-
ceptors.
To clarify potential unintended in vitro selection pres-
sures and to help explain anecdotal reports of unex-
pected infection profiles, we also evaluated a large panel
of tissue culture cell lines commonly used either to
propagate virus or as targets for infection to unveil po-
tential sources of background. Based on the results
obtained from RT-PCR, GPR1, GPR15, and STRL33 are
differentially expressed in a variety of primary cells and
commonly used cell lines (Fig. 2 and Table 3). GPR1 was
not widely expressed and was found only in U87, 293T,
HeLa, and CEMss cells. Interestingly, although GPR1 has
been reported to be expressed in alveolar macrophages
(Farzan et al., 1997a), we did not detect GPR1 transcripts
in peripheral monocytes or monocyte-derived macro-
phages. This finding may reflect real differences in co-
receptor expression among macrophage subsets, which
could have an impact on pathogenesis, although the
inability of the pulmonary isolate BaL to use GPR1 even
in fusion assays suggests that the use of GPR1 would
not be required for pulmonary infection. GPR15 was
more commonly expressed in the cell types examined.
GPR15 transcripts were present in CEMx174, Hut-78,
C8166, PM1, U937, PBMCs, monocytes, and macro-
phages. STRL33 was found in all cell lines examined.
Previous work has shown that rhesus as well as human
PBMCs express GPR15 and STRL33 but not GPR1 (Deng
et al., 1997; Edinger et al., 1997b; Farzan et al., 1997a;
Liao et al., 1997). The enhanced sensitivity of RT-PCR,
particularly followed by nested PCR, over Northern blot-
ting likely explains the discrepancies observed between
our positive STRL33 expression data for Hut-78, Jurkat,
Sup-T1, CEM, U937, and monocytes and the negative
data from previous publications (Deng et al., 1997; Liao et
al., 1997). The expression pattern of these orphan recep-
tors should be considered when designing experiments
to study coreceptor use both to lower background and
because it is not yet clear whether interactions between
chemokine receptors can influence their ability to serve
as coreceptors.
It is important to note that detection of message by
RT-PCR in a given cell type does not necessarily mean
that the receptor is expressed on the cell surface at
levels sufficient to support virus infection. Only when
ligands for the orphan receptors are identified or when
antibodies are developed can this point be rigorously
addressed. Expression levels of CCR5 and CCR3 are
known to be an important parameter governing cellular
susceptibility to virus infection (Kozak et al., 1997; Platt et
al., 1998; Rucker et al., 1997b), and it is likely that this will
hold true for the orphan receptors as well. We found that
transiently transfected cells expressed more CCR5 on
the cell surface than the GHOST stable cell line but
nearly equivalent levels of CD4. If this difference in co-
receptor expression holds true for the GHOST cells bear-
ing the orphan receptors, it could explain why some virus
strains showed a decreased ability to use orphan recep-
tors for virus infection when GHOST lines were used
(Figs. 1a and 1b). Previous studies have shown that with
high levels of CD4 expression, low levels of CCR5 are
adequate for infection (Platt et al., 1998), and we ob-
served equivalent signals for infection through CCR5 on
transfected 293T cells and on GHOST-CCR5 cells (data
not shown). It may be that higher levels of GPR15 and
STRL33 than of CCR5 are required to serve as corecep-
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tors in the presence of equivalent amounts of CD4, sug-
gesting that coreceptor activity is more concentration
dependent for the orphan receptors.
In summary, the available evidence leads us to con-
clude that the orphan receptors tested here are rarely
used as coreceptors by HIV-1. None of the HIV-1 strains
tested used the orphan receptors efficiently for cell–cell
fusion or virus infection even though the transient ex-
pression systems used in our assays likely result in
overexpression of these molecules. However, GPR1,
GPR15, and STRL33 are expressed in relevant target
cells, so they may participate in viral propagation to
some degree. In the case of SIV, the use of GPR1 and
particularly GPR15 and STRL33 was more widespread,
making it more likely that these receptors represent
important SIV coreceptors in vivo. Once ligands and
antibodies to GPR1, GPR15, and STRL33 become avail-
able, these tools can be used to further address the
potential relevance of these molecules for the finer levels
of HIV and SIV tropism.
MATERIALS AND METHODS
Cell–cell reporter gene fusion assay
This assay has been described elsewhere (Nussbaum et
al., 1994; Rucker et al., 1997a). Briefly, QT6 effector cells
were prepared by infection with a vaccinia virus encoding
the T7 polymerase and then transfection with plasmids
bearing the env genes under the control of the T7 promoter
or co-infection with Env-producing recombinant vaccinia
viruses. Env constructs introduced into effector cells via
recombinant vaccinia virus included SIVmac251 (v194), SIV-
mac239 (vCB74), SIVmac316 (vCB75), SIVmac316mut
(vCB76), DH12, RF (vCB36), BK132 (vCB51), ADA (vCB39),
JR-FL (vCB28), IIIB (vSC60, BH8 clone), and HIV-2 ST (vvST,
obtained from the AIDS Repository). Target cells were pre-
pared by transient transfection of QT6 cells with plasmids
encoding CD4 and the human coreceptor of interest under
the control of the CMV promoter and with luciferase under
the control of the T7 promoter. Effector and target cells were
mixed, and luciferase activity in cell lysates quantified 7–8
h after mixing.
Luciferase reporter viruses
Luciferase reporter viruses were prepared by trans-
fecting 293T cells with plasmids encoding the indicated
Envs and with the NL4–3 luciferase virus backbone
(pNL-Luc-E2R2) (Chen et al., 1994; Connor et al., 1995).
Target cells for SIV and HIV Env infection were human
293T or feline CCCS cells in which CD4 and coreceptors
were introduced by calcium phosphate transfection. Be-
cause 293T cells express CXCR4, these cells were not
used as targets for X4 viruses. Cells were lysed 3–4 days
p.i. by resuspension in 0.5% Triton X-100 in PBS and
assayed for luciferase activity.
FACS staining
The 293T cells were transfected using calcium phos-
phate precipitation with 2 mg of CD4 and 1 mg of CCR5
plasmids per well of a 24-well plate at 24 h before
staining for FACS. GHOST-CCR5 cells were low passage
and maintained in the recommended triple-selection me-
dia. Cells were lifted with 0.5 mM EDTA in PBS and
incubated for 30 min with 10 mg/ml normal mouse IgG
(Sigma Chemical, St. Louis, Missouri), anti-CCR5 anti-
body (Clone 45531, R&D Systems, Minneapolis, Minne-
sota), or CTC8 (Protein Design Labs, Moutain View, Cal-
ifornia) or with anti-CD4 antibody Q4120 directly conju-
gated to phycoerythrin (Sigma, used at a concentration
recommended by the manufacturer). CCR5 antibodies
and the isotype control were detected by PE-conjugated
horse anti-mouse IgG (Vector Labs, Burlingame, Califor-
nia). Cells were washed twice with PBS containing 2%
fetal calf serum after addition of either the primary or
secondary antibody and were analyzed using a Becton-
Dickinson FACScanner and the Cell Quest software.
Primary cells
Human PBMCs were isolated from the blood of
normal volunteers using Ficoll-Hypaque, depleted of
monocytes by serial adherence to plastic, stimulated
with PHA-L (5 mg/ml; Sigma) for 3 days and then
resuspended in media with IL-2 (20 U/ml; Boehringer-
Mannheim Biochemicals, Indianapolis, Indiana). RNA
was extracted after 3 days of PHA stimulation and also
after 1 week in IL-2. RNA was also extracted from
PBMCs cultured overnight on OKT3-coated plates fol-
lowed by propagation in 100 U/ml rIL-2. Monocytes
were purified from PBMCs by selective adherence to
gelatin followed by plastic and then maintained in
culture to allow differentiation into monocyte-derived
macrophages (MDM) as previously described (Coll-
man et al., 1989). RNA was extracted from undifferen-
tiated monocytes immediately after purification and
from MDM after 1 week in culture.
RT-PCR
To isolate total cellular RNA, 5–10 3 106 cells were
resuspended in 1 ml of Trizol reagent and processed as
recommended by the manufacturer (GIBCO BRL, Grand
Island, New York). Total RNA was then treated with 1 ml of
DNase (RNase-free) (Boehringer-Mannheim) per 10 mg of
RNA for 30 min at 37°C in the presence of 5 mM MgCl2 with
subsequent inactivation at 65°C for 10 min in the presence
of 5 mM EDTA. RNA concentration was calculated based
on the A260. The Titan RT-PCR system (Boehringer-Mann-
heim) was used to evaluate RNA expression patterns. In the
initial RT-PCR reaction, specific upstream and downstream
primers were used that corresponded to the 59 and 39 ends
of the gene coding sequence. Thus, the RT-PCR product
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was the length of the coding sequence (1073, 1080, or 1026
bp for GPR1, GPR15, and STRL33, respectively). For subse-
quent nesting reactions (and hemi-nesting in the case of
GPR1), internal primers were used to amplify 465-, 299-, or
385-bp fragments, respectively, using Taq DNA polymerase
(GIBCO BRL). GPR1 and GPR15 lack introns in the coding
region (Heiber et al., 1994; Marchese et al., 1994). It is not
known whether STRL33 contains introns. Thus, to control
for contamination of the RNA sample with genomic DNA
despite DNase treatment, all RNA samples were also am-
plified with Titan enzyme mix in which the RT but not PCR
activity had been destroyed by treatment at 95°C for 10 min.
This inactivation protocol was found to eliminate the ability
to amplify a RNA but not a DNA template. The RT-minus
sample was included in the nesting reaction as a negative
control. In each RT-PCR, U87 or CEMX174 RNA was in-
cluded as an RNA control and plasmid DNA was included
as a second positive control. The full-length primer se-
quences used were GPR1 forward, 59-CATGGAAGATTTG-
GAGGAAAC-39, and reverse, 59-ACTTATTGAGCTGTTTCC-
AGG-39; GPR15 forward, 59-CGGTAGGATTCACCATGGAC-
CCAGAAGAAACTTC-39 (contains an EcoRI site), and re-
verse, 59-TGCGCTCTAGATTAGAGTGACACAGACCTCTTCC-39
(contains a XbaI site); and STRL33 forward, 59-CGGGA-
ATTCCATGGCAGAGCATGATTACC-39 (contains an EcoRI
site), and reverse, 59-GCTCTAGACCCTGGCAAGGCCTA-
TAACTG-39 (contains a XbaI site). Primers designed for
nesting reactions were GPR1 forward primer (above)
used with the reverse primer, 59-AGAGTTCTTGAGGGT-
TCGATGCCG-39; GPR15 forward, 59-CTGGTTTATCTCCT-
GCCTGCTGGG-39, and reverse, 59-GGCAGCCAGGAGA-
CAAGAAAGGC-39; and STRL33 forward, 59-CCAGGAGG-
AGCATCAAGACTTCC-39, and reverse, 59-AGGTCATCCT-
GTTGGCTTGCTGG-39. b-Actin primers were described
by Samson et al. (1998).
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